Evidence map›Paper›PMID 37227189›Full record

ArticleEndocrinology, diabetes & metabolism case reports2023

Insulinoma with equivocal imaging.

Wafa Belabed, Fatma Mnif, Abdel Mouhaymen Missaoui, Mouna Elleuch, Dhoha Ben Salah, Nadia Charfi, Mouna Mnif, Nabila Rekik, Faten Hadj Kacem, Mohamed Abid

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wafa BelabedDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.ORCID 0000-0001-8835-0272
Fatma MnifDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Abdel Mouhaymen MissaouiDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.ORCID 0000-0002-2486-4597
Mouna ElleuchDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Dhoha Ben SalahDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Nadia CharfiDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Mouna MnifDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Nabila RekikDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Faten Hadj KacemDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Mohamed AbidDepartment of Endocrinology and Diabetology, Hedi Chaker University Hospital, Sfax, Tunisia.
Hopital Universitaire Hedi Chaker · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: A 55-year-old patient was admitted to our department for the management of a repetitive alteration of consciousness. Biological investigation results were consistent with endogenous hyperinsulinemic hypoglycemia. Insulinoma was therefore suspected. Abdominal computed tomography and endoscopic ultrasound showed no obvious pancreatic mass.Somatostatin receptor scintigraphy showed abnormal radioactive uptake in both the pancreatic tail and the uncinate process. Contrariwise, abdominal magnetic resonance imaging showed a unique lesion in the pancreas tail. The patient was then proposed for pancreatic surgery. Both intraoperative manual palpation and intraoperative ultrasonography of the pancreas showed a single corporal lesion of 1.5 cm. No lesion was found in the uncinate process. After a left pancreatectomy, the lesion was histopathologically confirmed to be a well-differentiated neuroendocrine tumor. The symptoms of the patient resolved almost immediately following the surgery. The follow-up is one and a half years to date. Learning points: The exact preoperative localization of the pancreatic mass remains the most challenging part of insulinoma diagnostic workup. The radiologist's experience is the best warrantor to a precise localization of the tumor. 111In-DTPA-octreotide uptake in the pancreatic uncinate process may be physiological and its interpretation must, therefore, be vigilant. Manual palpation along with intraoperative ultrasonography is considered as the most effective method for the localization of insulinomas during open surgery.

Identifiers

PMID37227189
PMCPMC10337269
OpenAlexW4378172621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.